back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-10 15:47 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
46 - Compensation for services
|
+384,615 vol |
384,615 | |
| Filed 2024-01-10 15:44 Tx date 2023-04-01 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-06 13:27 Tx date 2023-04-01 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
116,400 | ||
| Filed 2023-04-06 12:47 Tx date 2023-04-01 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-205,334 vol |
0 | |
| Filed 2023-04-06 12:46 Tx date 2023-04-01 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,692,024 vol |
0 | |
| Filed 2023-04-06 12:44 Tx date 2023-04-01 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-422,000 vol |
0 | |
| Filed 2023-01-18 19:10 Tx date 2022-12-31 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
59 - Exercise for cash
|
-102,666 vol |
205,334 | |
| Filed 2021-12-23 18:23 Tx date 2021-12-20 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+308,000 vol |
308,000 | |
| Filed 2021-12-23 18:22 Tx date 2017-12-01 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-27 16:18 Tx date 2020-12-31 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+492,024 vol |
1,692,024 | |
| Filed 2019-12-16 15:11 Tx date 2019-12-12 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,200,000 | |
| Filed 2019-06-27 18:19 Tx date 2019-06-27 |
$VIVO
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,680
+22,000 vol $0.44 each |
422,000 | |
| Filed 2018-12-13 Tx date 2018-12-12 |
$ABCN
VIVO Cannabis Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$267,000
+300,000 vol $0.89 each |
900,000 | |
| Filed 2017-12-08 Tx date 2017-12-01 |
$ABCN
ABcann Global Corporation |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2017-12-08 Tx date 2017-12-01 |
$ABCN
ABcann Global Corporation |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+400,000 vol |
400,000 | |
| Filed 2017-12-08 Tx date 2017-12-01 |
$ABCN
ABcann Global Corporation |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-20 Tx date 2017-07-17 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-12,375
-7,500 vol $1.65 each |
0 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-100,000 vol |
25,000 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-16,250
-25,000 vol $0.65 each |
0 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-86,625
-52,500 vol $1.65 each |
0 | |
| Filed 2016-12-29 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,500
+7,500 vol $1.00 each |
7,500 | |
| Filed 2016-12-29 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,422
+5,422 vol $1.00 each |
||
| Filed 2016-12-21 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+25,000 vol $1.00 each |
125,000 | |
| Filed 2016-12-21 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
56 - Grant of rights
|
+12,500 vol |
62,500 | |
| Filed 2016-12-21 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
57 - Exercise of rights
|
$-10,000
-10,000 vol $1.00 each |
52,500 | |
| Filed 2016-12-21 Tx date 2016-12-16 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,422
+5,422 vol $1.00 each |
5,422 | |
| Filed 2016-12-21 Tx date 2016-07-01 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-21 Tx date 2016-07-15 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
97 - Other
|
$83,500
+50,000 vol $1.67 each |
50,000 | |
| Filed 2016-07-21 Tx date 2016-07-01 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-21 Tx date 2016-07-15 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,000
+100,000 vol $1.67 each |
100,000 | |
| Filed 2016-07-21 Tx date 2016-07-01 |
$MSL
Merus Labs International Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-08 Tx date 2016-03-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
600,000 | |
| Filed 2015-08-10 Tx date 2015-08-07 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2015-08-10 Tx date 2015-08-04 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-05 Tx date 2015-08-05 |
$ATE
Antibe Therapeutics Inc. |
Bumby, Michael Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-475,000 vol |
0 |